EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 304 filers reported holding EDITAS MEDICINE INC in Q4 2021. The put-call ratio across all filers is 3.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,199,224 | -32.6% | 135,200 | -7.0% | 0.13% | +48.2% |
Q3 2022 | $1,780,000 | -11.5% | 145,400 | -14.5% | 0.08% | -5.6% |
Q2 2022 | $2,011,000 | -37.8% | 170,000 | 0.0% | 0.09% | -24.4% |
Q1 2022 | $3,233,000 | -32.3% | 170,000 | -5.6% | 0.12% | -29.6% |
Q4 2021 | $4,779,000 | -35.4% | 180,000 | 0.0% | 0.17% | -41.5% |
Q3 2021 | $7,394,000 | -23.2% | 180,000 | +5.9% | 0.29% | -20.4% |
Q2 2021 | $9,629,000 | +73.7% | 170,000 | +28.8% | 0.36% | +88.1% |
Q1 2021 | $5,544,000 | +46.4% | 132,000 | +144.4% | 0.19% | +13.5% |
Q4 2020 | $3,786,000 | +285.5% | 54,000 | +54.3% | 0.17% | +314.6% |
Q3 2020 | $982,000 | -5.1% | 35,000 | 0.0% | 0.04% | -28.1% |
Q2 2020 | $1,035,000 | +49.1% | 35,000 | 0.0% | 0.06% | +14.0% |
Q1 2020 | $694,000 | -8.1% | 35,000 | +37.3% | 0.05% | +19.0% |
Q4 2019 | $755,000 | +30.2% | 25,500 | 0.0% | 0.04% | +23.5% |
Q3 2019 | $580,000 | +123.1% | 25,500 | +142.9% | 0.03% | +126.7% |
Q2 2019 | $260,000 | – | 10,500 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |